V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003594 | 310006647 | 1.58 | 52.1 | Curative (C) | 2014-11-06 | 2014-11-07 | CHOP R - 21 days | 02 | N | 310018261 | CHOP R |
| 310003595 | 310001503 | 1.79 | 63.9 | Curative (C) | 2013-08-28 | 2013-08-27 | Cisplatin 7 day | 02 | Y | 310018269 | CISPLATIN |
| 310003596 | 310001503 | 1.6 | 54 | Curative (C) | 2015-09-10 | 2015-09-22 | Cisplatin | 02 | N | 310018269 | CISPLATIN |
| 310003597 | 310001503 | 1.68 | 95 | Palliative (P) | null | 2015-11-10 | CISPLATIN + GEMCITABINE | N | N | 310018269 | CISPLATIN + GEMCITABINE |
| 310003598 | 310001504 | null | 78.8 | Palliative (P) | 2013-04-04 | 2013-04-04 | Trial Unspecified | 1 | N | 310018274 | TRIAL |
| 310003599 | 310001504 | null | 65.1 | Palliative (P) | 2015-05-13 | 2015-05-27 | PEMBROLIZUMAB | N | N | 310018274 | PEMBROLIZUMAB |
| 310003600 | 310001505 | 1.58 | 50.3 | Curative (C) | 2014-08-31 | 2014-10-07 | Cisplatin | N | N | 310018278 | CISPLATIN |
| 310003601 | 310001506 | 1.56 | 74 | Curative (C) | 2016-08-08 | 2016-08-19 | Cisplatin | 02 | Y | 310018279 | CISPLATIN |
| 310003602 | 310001506 | 1.7 | 62.1 | Palliative (P) | 2015-03-04 | 2015-03-23 | Ipilimumab | 02 | N | 310018279 | IPILIMUMAB |
| 310003603 | 310001506 | 1.64 | null | Palliative (P) | 2016-07-08 | 2016-07-08 | DOXORUBICIN | 2 | N | 310018279 | DOXORUBICIN |
| 310003605 | 310001507 | 1.52 | 70.3 | Palliative (P) | 2015-05-22 | 2015-05-23 | PEMBROLIZUMAB | 2 | N | 310018290 | PEMBROLIZUMAB |
| 310003606 | 310001507 | 0 | 99.9 | Curative (C) | 2014-11-22 | 2014-11-25 | Retinoblastoma JOE | N | N | 310018290 | CEV |
| 310003607 | 310001507 | 0 | 89 | Curative (C) | null | 2016-08-21 | Retinoblastoma JOE | N | N | 310018290 | CEV |
| 310003609 | 310001509 | 1.55 | 62.6 | Palliative (P) | 2017-06-19 | 2017-07-11 | Doxorubicin 75mg/m2 | N | N | 310018298 | DOXORUBICIN |
| 310003610 | 310001510 | 1.55 | 62.6 | Adjuvant (A) | 2017-11-05 | 2017-11-07 | Trial Unspecified | Y | N | 310018299 | TRIAL |
| 310003611 | 310001511 | 1.69 | 8.6 | Palliative (P) | 2014-12-22 | 2014-12-23 | PEMBROLIZUMAB | N | N | 310018300 | PEMBROLIZUMAB |
| 310003612 | 310001511 | 1.58 | 109.8 | Curative (C) | 2014-04-27 | 2014-05-17 | CHOP R - 21 days | 2 | N | 310018300 | CHOP R |
| 310003613 | 310001512 | null | 53.6 | Palliative (P) | 2017-12-29 | 2018-01-05 | PEMBROLIZUMAB | 02 | N | 310018307 | PEMBROLIZUMAB |
| 310003614 | 310001512 | 1.83 | 84.3 | Palliative (P) | 2016-01-22 | 2016-02-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310018307 | CISPLATIN + GEMCITABINE |
| 310003615 | 310001512 | 1.59 | 69.3 | Adjuvant (A) | 2014-11-08 | 2014-12-06 | Cisplatin | 02 | Y | 310018307 | CISPLATIN |
| 310003616 | 310001513 | 1.74 | 15 | Adjuvant (A) | 2015-06-10 | 2015-06-20 | CISPLATIN + GEMCITABINE | N | N | 310018316 | CISPLATIN + GEMCITABINE |
| 310003617 | 310001513 | 0 | 56.2 | Curative (C) | 2013-08-08 | 2013-08-15 | Retinoblastoma JOE | N | N | 310018316 | CEV |
| 310003618 | 310001513 | 0 | 75 | Curative (C) | 2013-08-16 | 2013-08-19 | Retinoblastoma JOE | 02 | null | 310018316 | CEV |
| 310003619 | 310001514 | 1.72 | null | null | 2015-11-29 | 2015-11-29 | CHOP R - 21 days | 2 | N | 310018321 | CHOP R |
| 310003620 | 310001515 | 1.9 | 93.9 | null | 2016-06-03 | 2016-06-18 | Trial Unspecified | Y | N | 310018322 | TRIAL |
| 310003621 | 310006655 | 1.78 | 71.5 | Palliative (P) | 2016-03-05 | 2016-03-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310018323 | CISPLATIN + GEMCITABINE |
| 310003623 | 310001516 | 1.64 | 65 | Palliative (P) | 2014-10-28 | 2014-11-14 | CISPLATIN + GEMCITABINE | N | N | 310018326 | CISPLATIN + GEMCITABINE |
| 310003624 | 310001516 | 1.78 | 65.8 | Adjuvant (A) | 2016-06-27 | 2016-07-28 | CISPLATIN + GEMCITABINE | N | N | 310018326 | CISPLATIN + GEMCITABINE |
| 310003625 | 310001516 | 1.87 | 92.2 | Curative (C) | 2016-10-01 | 2016-10-05 | Cisplatin | N | null | 310018326 | CISPLATIN |
| 310003627 | 310001518 | null | 101.3 | Palliative (P) | 2015-08-25 | 2015-08-25 | Ipilimumab | N | N | 310018331 | IPILIMUMAB |
| 310003628 | 310001519 | 1.76 | 69.7 | Palliative (P) | 2015-05-20 | 2015-06-10 | ICON8 TRIAL | 02 | N | 310018334 | ICON TRIAL |
| 310003629 | 310001519 | 0 | 0 | Disease modification (D) | 2015-12-26 | 2015-12-26 | IMATINIB | N | N | 310018334 | CAPECITABINE |
| 310003630 | 310001519 | 1.51 | 68.2 | Curative (C) | 2013-01-25 | 2013-03-01 | Capecitabine + Cisplatin | N | N | 310018334 | CAPECITABINE + OXALIPLATIN |
| 310003631 | 310001519 | 1.55 | 58.1 | Neo-adjuvant (N) | 2017-07-28 | 2017-07-30 | EOX | N | N | 310018334 | CISPLATIN + FLUOROURACIL |
| 310003632 | 310001520 | 1.75 | 0.3 | Palliative (P) | 2013-10-28 | 2013-11-10 | IMATINIB | N | N | 310018341 | ICON TRIAL |
| 310003633 | 310001521 | 1.66 | 84 | Curative (C) | 2015-12-16 | 2015-12-30 | null | N | N | 310018342 | NOT MATCHED |
| 310003634 | 310001522 | null | 82.6 | Palliative (P) | 2015-12-12 | 2015-12-26 | GEM-P | null | null | 310018345 | RITUXIMAB |
| 310003635 | 310001522 | 1.59 | 66 | Disease modification (D) | 2013-11-11 | 2013-11-11 | Gemcitabine weekly | 02 | N | 310018345 | GEMCITABINE |
| 310003636 | 310001522 | 1.72 | null | Neo-adjuvant (N) | 2016-08-26 | 2016-09-01 | EOX | N | N | 310018345 | CAPECITABINE + OXALIPLATIN |
| 310003637 | 310001522 | 1.51 | null | Palliative (P) | 2017-03-30 | 2017-04-14 | ICON8 TRIAL | N | N | 310018345 | CAPECITABINE + CISPLATIN |
| 310003638 | 310001522 | 0 | 77.7 | Palliative (P) | 2016-01-17 | 2016-02-01 | CISPLATIN + FLUOROURACIL | N | N | 310018345 | IMATINIB |
| 310003639 | 310001523 | 1.8 | 66.9 | null | 2015-03-30 | 2015-04-10 | IPILIMUMAB + NIVOLUMAB | 02 | N | 310018351 | BCG |
| 310003640 | 310006659 | null | null | Neo-adjuvant (N) | 2014-01-23 | 2014-01-30 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | 310018355 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003641 | 310009084 | 1.58 | 62.6 | Palliative (P) | 2018-03-15 | 2018-04-09 | GEMCITABINE | N | N | 310018356 | GEMCITABINE |
| 310003642 | 310009084 | null | 77.65 | null | 2017-03-22 | 2017-03-30 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | null | 310018356 | NOT MATCHED |
| 310003643 | 310001524 | 1.65 | 58.1 | Palliative (P) | 2015-11-30 | 2015-11-30 | Capecitabine + Cisplatin | N | N | 310018360 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003644 | 310001524 | 1.75 | 9.2 | Palliative (P) | 2015-09-17 | 2015-10-17 | Cisplatin + Etoposide po&iv 3 day | N | N | 310018360 | HYDROXYCARBAMIDE |
| 310003645 | 310001524 | 1.57 | null | Palliative (P) | 2013-08-17 | 2013-08-17 | Liposomal Doxorubicin (Caelyx) | N | null | 310018360 | LIPOSOMAL DOXORUBICIN |
| 310003646 | 310001525 | 1.56 | 66.4 | Palliative (P) | 2014-09-13 | 2014-09-18 | Oxaliplatin + Modified de Gramont | 02 | N | 310018365 | HYDROXYCARBAMIDE |
| 310003647 | 310006661 | null | 65 | Adjuvant (A) | 2013-03-22 | 2013-03-28 | Crisantaspase + METHOTREXATE | N | N | 310018366 | NOT MATCHED |